Tumor inhibitors. XXXV. Myrsine saponin, the active principle of Myrsine africana L.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002849:Chromatography, Gas; D002854:Chromatography, Paper; D005002:Ethiopia; D005690:Galactose / Q000032:analysis; D005947:Glucose / Q000032:analysis; D005965:Glucuronates / Q000032:analysis; D006027:Glycosides / Q000032:analysis; D008745:Methylation; D009379:Neoplasms, Muscle Tissue / Q000188:drug therapy*; D010936:Plant Extracts / Q000032:analysis / Q000627:therapeutic use; D010944:Plants; D051381:Rats; D012210:Rhamnose / Q000032:analysis; D012503:Saponins / Q000032:analysis / Q000302:isolation & purification* / Q000627:therapeutic use
D005965:Glucuronates; D006027:Glycosides; D010936:Plant Extracts; D012503:Saponins; D005947:Glucose; D012210:Rhamnose; D005690:Galactose